To test the hypothesis that conditioning with a practical dose offish oil will reduce postprandial lipemia, 25 healthy men were matched according to levels of fasting plasma triacylglyceride and allocated to 6 weeks of either fish oil or olive oil supplements (5 g/day). After a 12-hour overnight fast at the termination of the study period, the subjects were given a standard test meal containing 89% of energy as fat (0.73 g fat/kg body wt, polyunsaturated to saturated fat ratio=0.4). Vitamin A (429 retinol equivalents/ kg body wt) was included to endogenously label the chylomicrons. Venous blood samples were obtained before the test meal and hourly thereafter for 8 hours. Chylomicrons were separated by ultracentrifugation, plasma triacylglyceride concentration was determined enzymatically, and retinyl ester levels were measured by liquid chromatography. Postprandially, the fish oil-fed group exhibited mean total and chylomicron triacylglyceride concentrations that were significantly (p<0.05) less than those of the olive oil-fed group. Both the fish oil-and olive oil-fed groups had similar rises in chylomicron retinyl esters during the first 2 hours, but after this time the postprandial response of the fish oil-fed group was consistently and significantly (p <0.05) less than the response of the olive oil-fed group. Our results suggest that improvement in lipemic response, whether due to enhanced chylomicron clearance or decreased chylomicron entry into the plasma pool, can be achieved at a much lower intake of fish oil than previously reported. (Arteriosclerosis and Thrombosis 1991;ll:457-466)
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To test the hypothesis that conditioning with a practical dose offish oil will reduce postprandial lipemia, 25 healthy men were matched according to levels of fasting plasma triacylglyceride and allocated to 6 weeks of either fish oil or olive oil supplements (5 g/day). After a 12-hour overnight fast at the termination of the study period, the subjects were given a standard test meal containing 89% of energy as fat (0.73 g fat/kg body wt, polyunsaturated to saturated fat ratio=0.4). Vitamin A (429 retinol equivalents/ kg body wt) was included to endogenously label the chylomicrons. Venous blood samples were obtained before the test meal and hourly thereafter for 8 hours. Chylomicrons were separated by ultracentrifugation, plasma triacylglyceride concentration was determined enzymatically, and retinyl ester levels were measured by liquid chromatography. Postprandially, the fish oil-fed group exhibited mean total and chylomicron triacylglyceride concentrations that were significantly (p<0.05) less than those of the olive oil-fed group. Both the fish oil-and olive oil-fed groups had similar rises in chylomicron retinyl esters during the first 2 hours, but after this time the postprandial response of the fish oil-fed group was consistently and significantly (p <0.05) less than the response of the olive oil-fed group. Our results suggest that improvement in lipemic response, whether due to enhanced chylomicron clearance or decreased chylomicron entry into the plasma pool, can be achieved at a much lower intake of fish oil than previously reported. (Arteriosclerosis and Thrombosis 1991;ll:457-466) E pidemiological and clinical evidence has shown that fish oil can lower plasma lipid levels. 1 -4 The plasma triacylglyceride (TAG)-lowering effect of large doses (>15 g fish oil/day) has been the best-documented effect. 3 At lower doses, the reported effects on plasma TAG have not always been significant although the downward trend has been consistent.
We 5 have established that a moderate intake of fish oil (5 g/day) for 6 weeks can reduce fasting plasma TAG levels in healthy men. Although fasting is a necessary standardization procedure to control for chylomicronemia, cardiovascular disease may also be influenced by postprandial blood levels. 6 - 8 Few studies have examined how fish oil-supplemented diets influence postprandial lipemia. In these few studies, 9 
"
13 pharmacological doses (18-120 g/day) were fed for periods of 2-4 weeks, and convincing reductions in postprandial lipemia were obtained, mostly relative to that for a saturated fat-based diet. Table 1 summarizes the study parameters (sample size, dosage, feeding period, and nature of fat given in the test meal) as well as the fasting and postprandial TAG results derived from these studies. The nature of fat given in the test meal was either the same as that given in the background diet (such as fish oil) or a predominantly saturated fat meal. Weintraub et al 13 incorporated vitamin A into their test meal to trace chylomicron and chylomicron remnant metabolism, whereas the other studies expressed lipemia solely by the rise in plasma TAG levels.
The aim of this study was to determine if longer-term conditioning with a moderate dose of fish oil, lower than that previously reported, could reduce postprandial lipemia. A standard fat meal (containing vitamin A) was given to healthy men at the end of 6 weeks of either fish oil or olive oil supplementation (5 g/day). Vitamin A in the form of retinyl esters (RE) is incorporated into the core of the chylomicron particle and, unlike TAG from a dietary fat load, enters a storage pool in the liver and so is not recycled into very low density lipoproteins (VLDLs).
14 Lipemic response was characterized in terms of both TAG and RE. Ref, reference number; TV, number of subjects; PUFAs, poh/unsaturated fatty acids; TAG, triacylglyceride; Sat, saturated fat load.
•Calculated as the percentage fall between TAG after the reference diet (T^) and TAG after the fish oil-feeding period (Tpo), i.e.,
V d O O
tThe test meal after the fish oil-feeding period was based either on fish oil (n-3) or on a predominant Sat.
Calculated from figures in the original articles by: [(T Rrf +AT Re f)-(TFo+ATpo)]/(T R rf+AT Rc( )xl00, where ATR^ and ATpo are the largest rises in TAG above baseline values (0 hour) for the reference and fish oil diets, respectively.
This study shows that small and practical amounts of n-3 polyunsaturated fatty acids (PUFAs) can have a significant impact on chylomicron metabolism and may contribute to the antiatherogenic effects of fish and fish oil in the diet.
Methods
Subjects and Treatment
We aimed to recruit at least 24 subjects (12 in each treatment group). An accurate sample size estimate was not possible due to insufficient data in the literature. Thirty-two healthy men were recruited from the University of Sydney staff and student population and were selected on the basis of being nonsmokers and normolipidemic with no family history of premature death from cardiovascular disease. The subjects were assessed to be healthy after they underwent a biochemical screen of 20 parameters (MBA-20). The protocol was explained to the volunteers, and written consent was obtained from them and from the University of Sydney's Medical Ethical Review Committee. The subjects completed a questionnaire designed to assess factors known to influence lipemic response, such as vigorous exercise 1516 and alcohol consumption. 17 They were asked to maintain their usual lifestyle habits and to refrain from the use of aspirin for the duration of the study (6 weeks). As an aspirin substitute, Tylenol (Sterling Laboratories, Ermington, Sydney, Australia) was made available. The subjects were matched according to their fasting plasma TAG concentrations and were allocated to 6 weeks of either fish oil or olive oil supplements (5 capsules/day=5 g/day). Allocation to either group was decided by the toss of a coin. The olive oil-fed group served as a reference rather than as a control group since no dietary oil can be considered metabolically inert.
Subjects were instructed to consume the five oil capsules one at a time throughout a daily meal to facilitate absorption 18 and to mask the identity of the oil. They were seen at biweekly intervals for issue of capsules and were contacted weekly to reinforce compliance. Seven individuals, five on fish oil and two on olive oil supplements, failed to complete the study, with two complaining of side effects. One subject attributed his weight gain 2 weeks after beginning the supplements to the 5 g/day of olive oil he was taking, while the other blamed a severe head cold on the fish oil supplements 1 week after commencing supplementation. Five subjects discontinued their participation in the study due to unforeseen commitments. The baseline characteristics (those given in Table 2 ) together with vigorous exercise and alcohol consumption were similar between those subjects who entered (JV=32) and those who successfully completed (N=25) the experiment ( Table 2 ). This study was conducted between September 1989 and April 1990.
Blinding and Assessment of Compliance
To blind the subjects as to which capsule they were taking, they were told that we were interested in testing four oils: polyunsaturated vegetable oil, fish oil, evening primrose oil, and olive oil. On the test day, they were asked which oil they thought they had been taking. All of the fish oil-fed group, many of whom had complained of "fishy eructations," correctly identified the oil supplement they had been taking. No subjects in the olive oil-fed group were able to correctly identify the oil supplement: two answered polyunsaturated vegetable oil; one, fish oil; Values are mean+SD with (ranges). BMI, body mass index; TAG, triacylglyceride; Choi, cholesterol; HDL-C, high density lipoprotein cholesterol. 'Total HDL-C determined by heparin-manganese precipitation of whole plasma. tSignificantly different from olive oil-fed group (p<0.05) by two-sample t test. tSigniflcantly different from presupplement values (p<0.02) by paired t test; not significantly different from fish oil-fed group after supplementation (p=0.54) by two-sample I test.
§Significantry different from presupplement values (/><0.02) by paired / test; not significantly different from olive oil-fed group after supplementation (p=0.11) by two-sample t test and one, evening primrose oil; whereas the majority (10/14) did not know.
Oil capsules were provided in 1-week lots with a number (one to five) of surplus capsules. The subjects were asked to return the leftovers so as to allow us to gauge the number of capsules apparently consumed. From the number of capsules given and the number of capsules returned, we could estimate the degree of apparent compliance by % Compliance = No. caps given -No. caps returned 100 x No. days on supplement 5 caps/day
As another measure of compliance for the fish oil-fed group, the erythrocyte membrane fatty acid profile after the supplementation period was compared with the baseline profile. We 5 have previously shown that there is a strong correlation (r=0.908) between dietary and erythrocyte eicosapentaenoic acid (EPA, 20:5n-3).
Protocol
Subjects were asked to refrain from drinking alcohol for 36 hours and from eating or drinking any beverage (apart from water) for 12 hours before each blood sample was taken. On entry to the study, weight, height, and waist-to-hip ratio were measured by the same observer as described in Brown et al. 5 Venous blood samples (20 ml) were taken from the fasting subjects for determination of baseline plasma TAG, cholesterol, and erythrocyte membrane fatty acid profile. At the end of 6 weeks of oil supplementation, weight and waist-to-hip ratio were again measured, and a blood sample was taken before administration of the fat tolerance test.
Test meal. The test meal, identical for both groups, was designed to supply a realistic serving of fat, made palatable by minimal protein and carbohydrate. The amount of fat given (0.8 g/kg body wt) was designed to represent that supplied by the major meal of the day (i.e., about half the daily fat intake of the average Australian male). The nature of the fat was designed to be neither exclusively "saturated" nor "polyunsaturated" but to exhibit a fatty acid profile typical of the average Australian diet (polyunsaturated to saturated fat ratio=0.4, see Table 3 ), as in vitro evidence suggests that polyunsaturated fatty acid-containing chylomicrons are more susceptible to lipolysis. 13 Vitamin A was included in the test meal to specifically label intestinally derived lipoproteins, the chosen dose (429 retinol equivalents/kg body wt) having been previously shown not to exceed the absorbance ability of the intestine.
14 For a 70-kg man, the test meal consisted of natural skim milk yogurt (90 g, Weight Watchers, Sydney, Australia), full cream (90 g, Dairy Farmers, Sydney, Australia: 31.5 g fat, 90 mg cholesterol), peanut oil (25 g, expeller pressed, Russell's Health Foods, Marrickville, Sydney, Australia), an aqueous solution of vitamin A in the form of retinyl palmitate (1.0 ml, 100,000 units, Micelle A, a gift from Bioglan Laboratories, Marrickville, Sydney, Australia), artificial Values are mean±SD and were derived from analyses of five randomly chosen oil capsules and six batches of the test meal performed in duplicate.
ND, not detected. tUnidentified components represent 3.4% and 0.5% of the total fatty acids for the fish oil (MaxEPA, RP Scherer Pty. Ltd., Huntington, Melbourne, Australia) and test meal, respectively. sweetener (1 g, 38 mg aspartame mixed into lactose, Equal, Searle Consumer Products, Crows Nest, Sydney, Australia), and vanilla essence (four drops, Queen Fine Foods, Alderley, Queensland, Australia). According to the package information and food tables, 19 5.5% of the 2,355 kJ was derived from both protein (7.6 g) and from carbohydrate (8.1 g) and 89% from fat (56.7 g). Fat extraction^ of six batches of the test meal indicated that the fat content was less (mean±SD=50.8±1.9 g) than that predicted by the Australian food tables, supplying an average of 0.73 g fat/kg body wt. The test meal was presented as a creamy viscous blend in a cup with a spoon provided. The cups and spoon were weighed before and after to determine the amount consumed. Subjects in the olive oil-and fish oil-fed groups ingested similar amounts of fat per kilogram of body weight (0.72±0.01 and 0.73±0.02 g, respectively). The fatty acid composition of the test meal and oil supplements are given in Table 3 .
Fat tolerance test procedure. After a 12-hour overnight fast, subjects were given the test meal between 8 and 9:30 AM to eat within 10 minutes, followed by a cup of weak jasmine tea without milk. The subjects found the test meal not unpleasant, and none experienced diarrhea or other gastrointestinal symptoms. All subjects remained sedentary and were allowed no food or liquid apart from a choice of water or weak jasmine tea without milk for 8 hours after the test meal. Blood samples (20 ml) were obtained with minimum venous stasis via a winged infusion set (21-gauge) inserted into an antecubital vein before the test meal (0 hour) and hourly thereafter for 8 hours.
Laboratory methods. Blood was collected into tubes containing K 2 EDTA (1.5 mg/ml) and centrifuged (l,700g, 10 minutes, 4°C) within an hour. Aliquots (3x0.5 ml) of plasma were stored (-80°C) for analysis of various hematologica] parameters. (These will be described elsewhere.) An aliquot (03 ml) was stored (4°C) for TAG and cholesterol analyses. A further aliquot (3.0 ml) of plasma was transferred to polycarbonate bottles and centrifuged (26,000g, 30 minutes, 18°C; 50Ti rotor, Beckman Instruments, Sydney, Australia), before being overlaid with saline (2.0 ml, d=1.006 g/ml, pH 7.4, 0.1 g/1 Na 2 EDTA), and recentrifuged under the same conditions. This second centrifugation was found to resolve the chylomicrons from lipoproteins of higher density. The top milliliter was aspirated and made up to volume (2.0 ml) with saline. The bottom 2 ml of infranatant was carefully removed by syringe without disturbing the saline interface. The supernatant and infranatant were divided into aliquots (2x1 ml) and stored (-80°C) for RE determination. One of the aliquots from the chylomicron-free infranatant (nonchylomicron fraction) was later thawed and analyzed for high density lipoprotein cholesterol (HDL-C). A further aliquot (0.3 ml) of the chylomicron fraction was stored (4°C) for TAG analysis.
Lipid and lipoprotein determination. Erythrocyte membranes were prepared, 21 and an aliquot (300 fil) of the erythrocyte ghosts was directly transesterified. 22 The fatty acid methyl esters were analyzed by flame ionization capillary gas chromatography as previously described.
5 HDL-C was determined by the method of Warnick et al. 23 After precipitation of the nonchylomicron fraction (200 /xl) with a mixture (20 fil, 1:1 vol/vol) of sodium heparin (3.17 g/100 ml physiological saline) and manganous chloride (40.06 g/100 ml), the supernatant was analyzed for cholesterol content. The nonchylomicron fraction was reflective of a fasting plasma sample as illustrated by the similarity of the HDL-C values for the fasting test day sample (whole plasma) (mean±SD=1.12±0.32 mM; N=25) versus the nonchylomicron fraction (mean±SD=1.16+0.31 mM; N=25). Cholesterol and TAG were measured enzymatically (CHOD-PAP Monotest, Boehringer-Mannheim, Mannheim, F.R.G., and MA-KIT 10 Triglycerides INT, Roche Diagnostics, Basel, Switzerland) using a centrifugal autoanalyzer (Cobas-Fara, Roche Diagnostics).
Retinyl ester determination. REs were determined in the chylomicron and nonchylomicron fractions by isocratic normal phase-liquid chromatography (HPLC adapted from References 24 and 25). All procedures were conducted quickly in subdued light.
An aliquot (200 fi\) of the chylomicron and nonchylomicron fraction was transferred to an Eppendorf tube by micropipette. Retinyl acetate in ethanol (200 nl, 546 fig/l) was added as an internal standard, and the tube's contents were vortex mixed (10 seconds). Heptane (150 fil, HPLC grade) was then added, and the tube was vortex mixed (10 seconds) and shaken (30 seconds). The mixture was centrifuged (10 minutes, 9,000g, 4°C). The heptane layer (120 fil) was drawn off by micropipette and transferred to an HPLC vial containing a glass insert (270 fi\). The extraction process was repeated after the addition of more heptane (120 fil). The capped HPLC vial was inverted and vortex mixed (10 seconds) before duplicate injections (100 fil each).
The HPLC system consisted of an ETP Kortec K65B automated sample injector (ICI, Ermington, Sydney, Australia), an LKB 2150 pump (LKB, Bromma, Sweden), an ETP Kortec K95-XR variablewavelength detector set at 325 nm with a range of 0.08 absorbance units, full scale, and a Shimadzu C-R3A integrator (Kyoto, Japan) with a chart speed set at 3.5 cm/min.
For the analyses we used prepacked 12.5-cmx4-mm (i.d.) columns filled with LiChrosorb Si 60 of 5-fim particle size (Merck, Darmstadt, F.R.G.). A 3-cmx4-mm (i.d.) guard column containing the same packing preceded the analytical column. The mobile phase consisted of 2.5% (vol/vol) dioxane/heptane and was purified and degassed immediately before use by passage through a 0.45-p,m (pore size) nylon filter (Kontes, Vineland, N.J.) under vacuum.
The REs eluted as two peaks. The major peak, eluting at 5 minutes, coeluted with authentic retinyl palmitate (type IV, Sigma Chemical Co., St. Louis, Mo.) and, in agreement with other reports, 26 -28 accounted for about 80% of the total RE recovered (mean±SD=82±7%). The minor peak, eluting at 4 minutes, presumably comprised longer-chain REs. The relative proportions of these two peaks remained constant throughout the test day. The amounts of REs in the chylomicron and nonchylomicron fractions, expressed as micrograms RE per liter plasma, were quantified by measurement of peak area and were related to standard curves for retinyl palmitate using retinyl acetate as an internal standard. The intra-assay and interassay variations were comparable and were lower for the chylomicron fraction (5% and 4%, respectively) than for the nonchylomicron fraction (12% and 9%, respectively). Although it has been suggested 14 -27 that after a vitamin A challenge the RE appearing in the nonchylomicron fraction (d< 1.006 g/ml) can be mostly attributable to that travelling in the core of the chylomicron remnants, uncertainty now exists about the intestinal origin of RE in this fraction. 29 
Statistical Methods
The effect of the oil supplementation on fasting plasma concentrations was ascertained by paired / test between the presupplementation and postsupplementation values and by two-sample / test after supplementation between the two oil groups.
The postprandial response to the test meal was characterized by a number of different methods for total TAG, chylomicron TAG, chylomicron RE, and nonchylomicron RE: 1) Two-way analysis of variance (ANOVA) was performed on the group data using hour (0-8) and treatment (olive oil versus fish oil) as the independent variables. 2) The average of the two highest rises above the baseline concentration (0 hour) was calculated from the equation 4) The area under the curve above the baseline concentration (0 hour) was calculated by the trapezoidal rule. 30 5) The postprandial increase in total TAG (from method 2 above) was normalized for fasting TAG concentrations (0 hour) to give the percent postprandial increase in TAGs
The latter four measures were tested for statistical significance between the oil supplementation groups by one-way ANOVA. A p value of 0.05 (two-tailed) was considered significant. Data are expressed as mean±SD in the text and tables and as mean±SEM in the figures. A statistical package (Macss, Statsoft Inc., Tulsa, Okla.) was used.
Results
On entry to the study, the baseline characteristics were similar for both groups apart from the fish oil-fed group being, on average, 10 years older than the olive oil-fed group. Because of the positive association between age and plasma cholesterol levels (r=0.500, N=32), total cholesterol was higher (but not significantly; p=0.08) in the fish oil-fed group. After the seven subjects discontinued the study, this tendency disappeared although the age difference (8 years) remained (Table 2) .
There was no change in anthropometric characteristics before and after the 6 weeks on oil supplements. Fasting plasma TAG levels fell significantly (19%) after fish oil supplementation. HDL-C tended to decrease after both oil supplements, significantly after the olive oil supplementation (11%; Table 2 ).
Compliance
After the supplementation period, all subjects in the fish oil-fed group showed enhanced incorporation of n-3 PUFAs (20:5, 22:5, and 22:6) at the expense of n-6 PUFAs (18:2, 20:3, 20:4, and 22:4) in their erythrocyte membranes. From Figure 1 (top) , it is apparent that there is a consistent increase (from 0.65% to 1.85% of the total fatty acids on average) in the percent proportion of EPA in the erythrocyte membranes of the fish oil-fed subjects, indicating subject compliance with the protocol. Although the percent proportion of 18:1 (oleic acid [n-9]+vaccenic acid [n-7]) increased on average after the olive oilsupplementation period, the increase was not consistent across the group (Figure 1, bottom) . From the returned capsule count, both oil-fed groups exhibited mean compliance of 98% (range for olive oil-fed group, 84-102%; for fish oil-fed group, 95-102%).
Postprandial Response to the Test Meal
After the test meal, plasma TAG levels increased in all subjects, tracking chylomicron TAG and peak- 
FIGURE 2. Line plots of postprandial response (mean±SEM) to a standard fat meal afier 6 weeks of oil supplementation (5 g/day) with either olive oil (n=14, a) or fish oil (n=U, • ) . Left panel: Response in total plasma triacylgtyceride (TAG, mM; -), with the fish oil group showing significantly lower values than the olive oil group by two-way analysis of variance (ANOVA) (p=0.0024). In the chylomicron TAG rise above fasting concentrations (--), the fish oil group has significantly lower values than the olive oil group by two-way ANOVA ( p=0.0364). Right panel: Response in chylomicron retinyl esters (RE, mg/l). The fish oil group showed significantly lower values than the olive oil group after 2 hours by two-way ANOVA ( p=0.0481).
ing at 3.5 hours at almost twice the fasting level (mean±SD=187±45%). Eight hours after the test meal, the TAG concentrations in 14 of the 25 subjects had fallen below their fasting levels (0 hour). On average, three quarters of the vitamin A load traveled with the chylomicron fraction. Chylomicron REs peaked at 3.4 hours at six times higher than the maximum rise in nonchylomicron REs, which peaked 1.5 hours later. As has been noted by others, 31 irregular postprandial response curves were observed. Of the total 25 subjects studied, 10 displayed one chylomicron TAG peak, 11 had two chylomicron TAG peaks, and four subjects had three chylomicron TAG peaks. The chylomicron RE curves were more regular with most subjects (18/25) , exhibiting a monophasic response, and the remainder had a biphasic response. Subjects displaying a monophasic response and those displaying a polyphasic response were homogeneously distributed between the oil supplementation groups.
Postprandially, the fish oil-fed group exhibited mean total TAG concentrations consistently and significantly {p=0.0024) less than that of the olive oil-fed group (Figure 2, left) . Logarithmic transformation of the data to correct for any potential bias caused by the upward skewing of TAG values maintained the significant difference between treatments (/><0.01 for total TAG, p<0.001 for chylomicron TAG). The difference between the two oil supplementation groups was mirrored in the significantly different (p=0.0364) chylomicron TAG curves above the baseline concentration (Figure 2, left) . Both the fish oil-and the olive oil-fed groups had similar rises in chylomicron REs during the first 2 hours, but after this time the response of the fish oil group was consistently and significantly (p<0.05) less than the response to olive oil (Figure 2, right) . The nonchylomicron RE curves (corrected for the fasting level) were not significantly different between the groups, nor were other measures of postprandial response significantly different (Table 4) . No difference was observed between the oil supplementation groups for either total or HDL-C responses to the test meal after adjusting for the fasting concentrations.
Discussion
This study has shown that the lipemic response to a standard fat meal (representing half of the daily fat intake) can be reduced by prior conditioning for 6 weeks by modest fish oil intake (5 g/day). Chylomicron metabolism, as measured by RE, was also modified by fish oil, showing a lower postprandial response after the first 2 hours (Figure 2, right) .
Previous studies (References 10-13, Table 1 ) have shown that conditioning with pharmacological doses of fish oil (equivalent to 6-28 g n-3 PUFAs/day) reduce postprandial TAG 10 "
13 and RE concentrations. 13 The novel observation of the present study is that these changes occurred at lower n-3 PUFA intakes (1.7 g/day) than previously reported. These Values are mean±SD. The statistics paragraph at the end of the "Methods" section describes how these characteristics of postprandial response were derived.
•Values for TAG in millimoles and for RE are in milligrams per liter. fValues for TAG are in millimoles-hour and for RE are in milligrams per literhour.
findings are consistent with those of Harris and Windsor, 32 who reported that supplementing the diets of 15 healthy individuals with 2.3 g n-3 PUFAs/ day for 4 weeks significantly lowered chylomicron TAG concentrations after a fat tolerance test.
The effect of long-term fish oil feeding in reducing postprandial lipemia may reflect lower fasting plasma TAG levels. Table 4 ). The primary mechanism underlying the fasting TAG-lowering effect of fish oil is reduced synthesis and secretion of VLDL. 34 The hypothesis proposed 12 ' 13 suggests that in the postprandial state, since chylomicrons and VLDL are in competition for the same mechanism of disposal (i.e., lipoprotein lipase [LPL]), the clearance of either of these lipoproteins should be dependent on thenrelative abundance.
-
35
- 37 Thus, in the fish oil group where hepatic VLDL production is reduced, chylomicron clearance may be accelerated.
Harris et al 12 argue that although this proposed explanation could hold for hypertriacylglyceridemic subjects, it is necessary to assume that LPL is saturated at "normal" TAG levels in normotriacylglyceridemic subjects (for the present study, mean=1.06 mM) but not saturated after fish oil supplementation (mean=0.79 mM). This was not assessed in the present study. Harris et al 12 suggested that changes in the fatty acid composition of cell membranes may alter the activity of membrane-bound enzymes in vivo. In the present study, we have shown that a moderate amount of fish oil alters the fatty acid composition of erythrocyte membranes, but it is not known whether this could, for example, stimulate LPL activity in vivo. Several studies have found that neither LPL nor hepatic TAG lipase activity was stimulated by fish oil feeding (35- All the explanations discussed above involve mechanisms for increased TAG removal. 12 ' 13 In the present study, because chylomicron clearance was not determined, decreased entry into the plasma pool cannot be dismissed as a possible explanation. Since the primary mechanism underlying the reduction in fasting TAG levels is reduced hepatic synthesis and secretion of VLDL, 34 it does not seem unreasonable to propose that one mechanism underlying the reduction in fasting TAG levels might be reduced synthesis and secretion of chylomicrons from the enterocyte. However, the mechanism(s) for the effect of long-term fish oil feeding in reducing postprandial lipemia must await direct experimental evaluation.
After both oil supplements, HDL-C levels decreased, significantly in the olive oil group (Table 2) . This is consistent with a study by Mensink et al, 39 who reported that in healthy men, HDL-C levels fell similarly after an olive oil-enriched diet as compared with those after a diet enriched with sunflower seed oil. In contrast, Grundy and coworkers 40 have noted that dietary monounsaturated fatty acids do not lower HDL-C levels when substituted for saturated fatty acids. Patsch et al 41 have reported that low HDL-C levels result in more pronounced lipemia. However, in the present study the fall was smaller than that reported by Patsch et al 41 (two subjects followed over 3 years), and no correlation was evident between HDL-C level and lipemic response. It is possible that the fall observed in HDL-C after both oil supplements may reflect a secular trend, which has been masked by the known HDL-C-raising effect of moderate amounts of fish oil. 3 Our results suggest that improvement in lipemic response can be achieved at a much lower intake of fish oil than previously reported. Chylomicron metabolism measured by both TAG and RE was enhanced in healthy men after 6 weeks of conditioning with fish oil relative to olive oil (5 g/day). In light of the hypothesis that atherosclerosis may, in part, be a postprandial phenomenon, 6 -8 these observations may help to explain the inverse relation between long-term fish consumption and mortality from coronary heart disease. 
